LakeShore Biopharma Unknown Indicator
| LSBDelisted Stock | | | 0.63 0.00 0.00% |
The Expected Shortfall lookup presents technical context for LakeShore Biopharma Co and related instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. LakeShore Biopharma has a market cap of 25.84 M, operating margin of -68.83%, ROE of -18.43%.
Correlation Analysis can help frame allocation decisions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
LakeShore Biopharma Co has current Expected Shortfall of 0.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.